Professor Dr. habil. Rares-Ionut Stiufiuc
ERA-Chair Holder
Professor Știufiuc received his PhD degree in Physics at the "Babeș-Bolyai" University in 2005 and habilitation Degree in Pharmaceutical Science at the "Iuliu Hațieganu" University of Medicine & Pharmacy of Cluj in 2017. During his PhD Thesis he was awarded with a Marie Curie fellowship at Laboratoaire de Physique des Solides, Universite Paris Sud XI (2003-2004). Between 2005-2007 he was employed as PostDoctoral Research Associate at Institute d’Électronique, Microelectronique et Nanotehnologie - IEMN, Lille, France. He is currently Professor and Coordinator of research activities at MedFUTURE – NanoBioPhysics Department at the "Iuliu Hațieganu" University of Medicine & Pharmacy of Cluj. His research activities are focused on the development of different types of multifunctional nanohybrids (magnetic, plasmonic & magnetoplasmonic nanoparticles, nanoliposomes, quantum dots, etc.) for biomedical applications such as targeted drug delivery, cancer treatment, biodetection, etc. He is also very much involved in the advancement of new early detection techniques mainly based on ultrasensitive vibrational spectroscopy performed on biofluids. Professor Stiufiuc’s scientific activity can be measured in 75 scientific papers published in high-impact journals (Science, Physical Chemistry Chemical Physics, Talanta, Analytical and Bioanalytical Chemistry, Journal of Cellular and Molecular Medicine, Cell Death & Disease, Pharmaceutics, Cancers, International Journal of Nanomedicine, Cell Death and Disease - Nature group, Journal of Liposome Research, Scientific Reports, etc.). As a recognition of his research activities in 2020 he received the Romanian Academy Prize for the „Development of multifunctional nanostructures with applications in Nanomedicine”.
As ERA-Chair he will lead the activities related to the creation of a multidisciplinary research team that will perform research activities in the field of NanoBioPhysics. These activities will be focused on the development of new multifunctional nanohybrids having a core/shell architecture and several functionalities that will be further characterized and tested in-vitro as well as in-vivo for theranostic applications. All these efforts have the clear goal of integration TRANSCEND research centre in the European Research Area by increasing the international visibility, expanding participation in collaborative projects, and promoting the translational capability.
